Related references
Note: Only part of the references are listed.Risk of Respiratory Syncytial Virus Infection in Cyanotic Congenital Heart Disease in a Subtropical Area
Shuenn-Nan Chiu et al.
JOURNAL OF PEDIATRICS (2016)
Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection
Michael T. Brady et al.
PEDIATRICS (2014)
Respiratory syncytial virus infections in infants and children with congenital heart disease: update on the evidence of prevention with palivizumab
Bernhard Resch et al.
CURRENT OPINION IN CARDIOLOGY (2013)
Chronic Diseases, Chromosomal Abnormalities, and Congenital Malformations as Risk Factors for Respiratory Syncytial Virus Hospitalization: A Population-Based Cohort Study
Kim Kristensen et al.
CLINICAL INFECTIOUS DISEASES (2012)
The risk of mortality among young children hospitalized for severe respiratory syncytial virus infection
Shelagh M. Szabo et al.
Paediatric Respiratory Reviews (2012)
Cost-effectiveness of Palivizumab for Respiratory Syncytial Virus Infection in High-risk Children, Based on Long-term Epidemiologic Data From Austria
Bernhard Resch et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Community-acquired Respiratory Infections in Young Children With Congenital Heart Diseases in the Palivizumab Era The Spanish 4-Season Civic Epidemiologic Study
Constancio Medrano Lopez et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2010)
Risk factors for respiratory syncytial virus hospitalisation in children with heart disease
K. Kristensen et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2009)
Nosocomial infection:: A risk factor for a complicated course in children with respiratory syncytial virus infection -: Results from a prospective multicenter German surveillance study
Arne Simon et al.
INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH (2008)
Palivizumab use in subjects with congenital heart disease
Stuart A. Cohen et al.
PEDIATRIC CARDIOLOGY (2008)
Respiratory syncytial virus infections in congenital heart defects - hospitalizations and costs
A Meberg et al.
ACTA PAEDIATRICA (2006)
Recommendations for RSV prophylaxis in children with congenital heart defects. Consensus paper of the Working Group for Pediatric Cardiology of the Austrian Society of Pediatric and Adolescent Medicine, 2004
M Pinter et al.
MONATSSCHRIFT KINDERHEILKUNDE (2005)
Low incidence of respiratory syncytial virus hospitalisations in haemodynamically significant congenital heart disease
A Duppenthaler et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2004)
Physiologic risk factors for respiratory viral infections and immunoprophylaxis for respiratory syncytial virus in young children with congenital heart disease
AK Cabalka
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease
TF Feltes et al.
JOURNAL OF PEDIATRICS (2003)
Respiratory syncytial virus in patients with congenital heart disease: A contemporary look at epidemiology and success of preoperative screening
CA Altman et al.
PEDIATRIC CARDIOLOGY (2000)
Share Paper
